Vaccines
Feature
How to talk to patients reluctant to get a COVID-19 vaccine
Many patients are just seeking more information experts say.
From the Journals
Is the WHO’s HPV vaccination target within reach?
The WHO’s goal is to have HPV vaccines delivered to 90% of all adolescent girls by 2030.
Latest News
Some with long COVID see relief after vaccination
People “tell me their brain fog has improved, their fatigue is gone, the fevers that wouldn’t resolve have now gone.”
Commentary
Let’s apply the lessons from the AIDS crisis to the COVID-19 pandemic
Looking back on the AIDS epidemic should teach us to prioritize attending to the mental health of sufferers and caregivers and depoliticizing...
From the Journals
COVID-related immunization gaps portend return of preventable infections
Reversal of herd immunity is possible in the face of growing vaccine hesitancy.
Applied Evidence
Anticipating the care adolescents will need
The HEADSS approach is one way to begin discussing key clinical and social topics and to guide further screening or intervention.
Practice Alert
ACIP recommendations for COVID-19 vaccines—and more
Prioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those >...
From the Journals
Armpit swelling after COVID-19 vaccine may mimic breast cancer
Some women have experienced axillary node swelling after receiving the Pzifer-BioNTech or Moderna COVID-19 vaccines. The swelling mimics symptoms...
Feature
COVID-19 vaccination linked to less mechanical ventilation
A new paper offers a “real-world” look at vaccination effectiveness, according to the authors.
News
FDA grants emergency use authorization to Johnson & Johnson COVID-19 vaccine
“The advantages of having a third vaccine, especially one that is a single shot and can be stored without special refrigeration requirements, will...
News from the FDA/CDC
J&J COVID-19 vaccine wins unanimous backing of FDA panel
The Johnson & Johnson vaccine is expected to offer more convenient dosing and be easier to distribute than the two rival products already...